Search Results for: ""
Resources
Zoom In on Dementia & Alzheimer's
Stroke, Vascular Dementia, Alzheimer's: What's the Difference?
Dr. Jason Hinman of UCLA explains how disrupted blood flow to the brain can lead to cognitive decline, how vascular dementia differs from (and often overlaps with) Alzheimer’s disease, and what the latest research means for prevention and treatment.
Macular Chats
Cell Therapy and Macular Degeneration: Exploring a New Treatment Frontier
In this episode, we explain how these therapies are intended to work, how the cells may be delivered to the eye, and the potential risks.
Zoom In on Dementia & Alzheimer's
Therapeutic TV for Alzheimer's: What the Research Shows
In this episode, Allyson Schrier shares how research following her experience caring for her husband with dementia led her to create a streaming service designed to calm, engage, and support people living with memory loss.
News
Understanding the Causes of Steroid-Induced Glaucoma
A commonly used medication is linked to increased risk of glaucoma. A BrightFocus National Glaucoma Research-funded scientist is trying to understand why.
Article
Can Better Sleep Slow Alzheimer's?
New BrightFocus-funded research suggests restoring sleep may help protect the brain from dementia progression, and a common insomnia drug could help lead the way.
Press Release
Dr. David Abramson Receives 2026 Helen Keller Prize for Vision Research from BrightFocus Foundation and Helen Keller Foundation
A pioneering clinician-scientist at Memorial Sloan Kettering Cancer Center, Dr. Abramson has transformed understanding and treatment of eye cancers worldwide.
Article
FDA Approves Repurposed Anti-Depressant to Treat Alzheimer's-Associated Agitation
Auvelity, developed by Axsome Therapeutics, was approved today by the U.S. Food & Drug Administration (FDA) for the treatment of Alzheimer’s disease agitation, a common and challenging symptom that affects 40 to 60 percent of people living with Alzheimer’s.
Press Release
BrightFocus Honors 5 Vision Scientists Advancing Breakthrough Eye Research
At a ceremony recognizing 2026 vision grant recipients, these prestigious awards honor five standout scientists whose work is shaping the future of prevention, treatments, and cures for macular degeneration and glaucoma—two leading causes of vision loss.
Macular Degeneration Research News: Spring 2026
In this issue: Switching Off a Harmful Protein Could Help Protect Vision, Doug Finds Hope Amid Vision Loss, How Ongoing Treatment Helps Slow Geographic Atrophy, and more!
Press Release
Donor Support Powers $16M+ Investment in 69 Projects Tackling Alzheimer's, Macular Degeneration, and Glaucoma
Following a year of uncertainty surrounding federal biomedical research funding, BrightFocus Foundation provides critical support for innovative brain and eye research.
General Information
-
Macular Degeneration Research
-
Bright Focus Foundation
-
Glaucoma Stay Up to Date
-
Dr. Daniel Stamer on Why He Donates to National Glaucoma Research
-
Macular Degeneration Research – 2026 Confirmation
-
Glaucoma Disease Research – 2026 Calendar
-
Let’s Talk Alzheimer’s Podcast
Let’s Talk Alzheimer’s is a podcast hosted by BrightFocus Foundation that helps listeners understand Alzheimer’s disease and other dementias through trusted scientific insight.
-
Alzheimer’s Disease Research – 2026 Winner
-
Alzheimer’s Disease Research – 2026 Calendar
